Paediatric Sedation With Intranasal Dexmedetomidine for Magnetic Resonance Imaging

BACKGROUND: Paediatric sedation for magnetic resonance imaging presents significant challenges. To facilitate this, our department decided to implement paediatric sedation with intranasal dexmedetomidine for children requiring a scan. We aim to summarise lessons learnt from implementation of intranasal dexmedetomidine, comparing time consumption and effectiveness. METHODS: We conducted a prospective observational study. Data from children sedated with intranasal dexmedetomidine 4 μg/kg (n = 51) were collected prospectively and compared with historical controls (n = 100) collected from children previously anaesthetized with either sevoflurane or propofol. RESULTS: Sedation with intranasal dexmedetomidine resulted in a longer hospital stay (214 min vs. 133 min [67.94-94.74]), longer time to sufficient sedation (60 min vs. 26 min [29.31, 38.68]) and longer time in the post-operative unit (112 min vs. 64, 48 min [36.11, 60, 80]). Of children sedated with dexmedetomidine, 75% were cooperative with the intranasal administration of the medicine and 37% were successfully sedated with dexmedetomidine as the sole sedative. In the historical controls, 43% of patients required airway management compared to 1.9% in the dexmedetomidine group [0.00, 0.19]. In the control group, 20% had post-sedation agitation compared to none in the dexmedetomidine group. No serious bradycardia or desaturation was registered in either group. CONCLUSION: Paediatric sedation with intranasal dexmedetomidine as the sole medicament for magnetic resonance imaging is more time-consuming compared to sevoflurane and propofol. Sedation with intranasal dexmedetomidine has a relatively low success rate but is without serious adverse events. EDITORIAL COMMENT: This single center case-control study with prospective datacollection for the case group, intranasal dexmedetomidine and comparison with a historical non-dexmedetomidine sedation group described multiple possible clinical advantages with intranasal dexmedetomidine administration as it was done here.

Authors

Institutions

Publication Details

Journal
Acta Anaesthesiologica Scandinavica
Published
2026-11-20
DOI
https://doi.org/10.1111/aas.70398
Primary Topic
Anesthesia and Sedative Agents
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Paediatric Sedation With Intranasal Dexmedetomidine for Magnetic Resonance Imaging

Sofie Ronja Petersen, Rajesh Prabhakar Bhavsar, Katrine Dueholm Nissen, Thomas Strøm et al.
1 links
Acta Anaesthesiologica Scandinavica
Anesthesia and Sedative Agents
article

Paediatric Sedation With Intranasal Dexmedetomidine for Magnetic Resonance Imaging

Sofie Ronja Petersen, Rajesh Prabhakar Bhavsar, Katrine Dueholm Nissen, Thomas Strøm, Caroline Margaret Moos, Andras Wolf, Jeppe Keller
article en

Abstract

BACKGROUND: Paediatric sedation for magnetic resonance imaging presents significant challenges. To facilitate this, our department decided to implement paediatric sedation with intranasal dexmedetomidine for children requiring a scan. We aim to summarise lessons learnt from implementation of intranasal dexmedetomidine, comparing time consumption and effectiveness. METHODS: We conducted a prospective observational study. Data from children sedated with intranasal dexmedetomidine 4 μg/kg (n = 51) were collected prospectively and compared with historical controls (n = 100) collected from children previously anaesthetized with either sevoflurane or propofol. RESULTS: Sedation with intranasal dexmedetomidine resulted in a longer hospital stay (214 min vs. 133 min [67.94-94.74]), longer time to sufficient sedation (60 min vs. 26 min [29.31, 38.68]) and longer time in the post-operative unit (112 min vs. 64, 48 min [36.11, 60, 80]). Of children sedated with dexmedetomidine, 75% were cooperative with the intranasal administration of the medicine and 37% were successfully sedated with dexmedetomidine as the sole sedative. In the historical controls, 43% of patients required airway management compared to 1.9% in the dexmedetomidine group [0.00, 0.19]. In the control group, 20% had post-sedation agitation compared to none in the dexmedetomidine group. No serious bradycardia or desaturation was registered in either group. CONCLUSION: Paediatric sedation with intranasal dexmedetomidine as the sole medicament for magnetic resonance imaging is more time-consuming compared to sevoflurane and propofol. Sedation with intranasal dexmedetomidine has a relatively low success rate but is without serious adverse events. EDITORIAL COMMENT: This single center case-control study with prospective datacollection for the case group, intranasal dexmedetomidine and comparison with a historical non-dexmedetomidine sedation group described multiple possible clinical advantages with intranasal dexmedetomidine administration as it was done here.

Acta Anaesthesiologica ScandinavicaVol. 71(1)
University of Southern Denmark (DK), Odense University Hospital (DK), Sygehus Sønderjylland (DK)
Good health and well-being
Anesthesia and Sedative Agents
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon